Cytological and immunological study of 139 patients with acute leukemia

Jun Minowada1, G Mathé2, Maurice Barcos1, M Ginsbourg2, Preisler Hd1, C Canon2, Peter Reizenstein2
1Roswell Park Memorial Institute, Buffalo, USA
2Institut de Cancérologie et d’Immunogénétique (I.N.S.E.R.M. U-50), Hopital Paul-Brousse, Villejuif Cédex, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Miller D R, Leikin S, Albo Y, Sather H, Hammond D: Prognostic importance of morphology (FAB classification) in childhood, acute lymphoblastic leukemia (ALL),Br J Haemat 48, 199 (1981).

Mathé G, Rappaport H, O’Conor G T, Torloni H: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. Geneva, World Health Organization (1976).

Minowada J, Sagawa K, Lok M S, Kubonishi I, Nakazawa S, Tatsumi E, Ohnuma T, Goldblum N: A model of lymphoid cell differentiation based on the study of marker profiles of 50 human leukemia-lymphoma cell lines, in Serrou B, Rosenfeld C (ed):International Symposium on New Trends in Human Immunology and Cancer Immunotherapy, p. 188. Paris, Doin publisher (1980).

Bernard A, Boumsell L, Reinherz E L, Nadler L M, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman S F: Cell surface characterization of malignant T-cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T-cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.Blood 57, 1105 (1981).

Nadler L M, Ritz J, Reinherz E L, Schlossman S T: Cellular origins of human leukemias and lymphomas, in Knapp W (ed).Leukemic Cell Markers, p. 3. New York, Academic Press (1982).

Kersey J H, Le Bien T W, Gajl-Peczalska K, Nesbit M, Jansen J, Kung P, Goldstein G, Qather H, Coccia P, Siegel S, Bleyer A, Hammond D: Acute lymphoblastic leukemia lymphoma: cell markers defined by phenotypic heterogeneity, in Knapp W (ed):Leukemic Cell Markers, p. 453. New York, Academic Press (1982).

von Fliedner V, Heumann D, Carrel S, Jeannet H, Morell A, Mach J P, Hirt A, Cruchaud A: Classification of acute leukemia using surface markers: a study of 111 cases, inUICC Conf. on Clinical Oncology and 7th Annual Meeting on the European Society of Medical Oncology, Lausanne, October 1981 (abstract 09-0228).

Canon C, Ogier C, Goutner A, de Vassal F, Reizenstein P, Mathé G: The common acute lymphoid leukemia antigen in blood, bone marrow and lymph nodes in lymphatic malignancies at diagnosis and in remission.

Beran M, Reizenstein P, Uden A M: Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parameters.Br J Haemat 44, 39 (1980).

Reizenstein P, Andersson B, Giannoulis N, Hast R, Nordenskjöld B, Skoog L, Thorell B: Staging and prognosis in acute myeloid leukemia (AML), in6th Annual Meeting of the European Society of Medical Oncology, Nice, December 1980.

Gajl-Peczalska K J, Bloomfield C D, Frizzera G, Kersey J H, Le Bien T W: Diversity of phenotypes of non-Hodgkin’s malignant lymphoma, in Vitteta E, Fox C F (eds):UCLA Symposium on Molecular and Cellular Biology. Vol. XXIV, New York, Academic Press, 1982 (in press).

Greaves M F: Monoclonal antibodies as probes for leukaemic heterogeneity and haemopoietic differentiation, in Knapp W (ed).Leukemic Cell Markers, p. 19. New York, Academic Press (1982).

Gullberg R, Reizenstein P: Granulocyte release of vitamin B12-bindersin vivo andin vitro in leukemia and non-neoplastic leucocytosis.Cand J Haemat 15, 377 (1975).

Hast R, Ogier C, Giannoulis N, Lindblom B, Sjögren A M, Andersson B, Uden A M, Reizenstein P: Staging of acute non-lymphocytic leukemia — a study of immune response like antigens, cellular antigenicity,in vitro colony and cluster formation and peroxidase reactivity.Europ. & African Div. 5th Meeting, Hamburg, 1979 (abstract).

Roberts M, Greaves M, Janossy G, Sutherland R, Pain C: Acute lymphoblastic leukaemia (ALL) associated antigens. I. Expression in different haematopoietic malignancies.Leuk Res 2, 105 (1978).

Skoog L, Andersson B, Giannoulis N, Hast R, Humla S, Hägerström T, Nordenskjöld B, Reizenstein P, Ost A: Glucorticoid receptor and terminal transferase as indicators of prognosis in acute nonlymphocytic leukemia (ANLL).Br Med J 282, 1826 (1981).

Zittoun R, Marie J P, Perrot J Y, Zittoun J, Boucheix C, Rosenfeld C: Membrane markers, TdT and ultrastructural cytochemistry in apparently nonmyeloid leukemias, inUICC Conf. on Clinical Oncology and 7th Annual Meeting on the European Society of Medical Oncology, Lausanne, October 1981 (abstract 09-0391).